These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11352235)

  • 1. Leflunomide-associated weight loss in rheumatoid arthritis.
    Coblyn JS; Shadick N; Helfgott S
    Arthritis Rheum; 2001 May; 44(5):1048-51. PubMed ID: 11352235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of previous and concomitant leflunomide on the efficacy and safety of infliximab therapy in patients with rheumatoid arthritis; a longitudinal observational study.
    Flendrie M; Creemers MC; Welsing PM; van Riel PL
    Rheumatology (Oxford); 2005 Apr; 44(4):472-8. PubMed ID: 15598707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group.
    Cohen S; Cannon GW; Schiff M; Weaver A; Fox R; Olsen N; Furst D; Sharp J; Moreland L; Caldwell J; Kaine J; Strand V
    Arthritis Rheum; 2001 Sep; 44(9):1984-92. PubMed ID: 11592358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasculitis associated with the use of leflunomide.
    Macdonald J; Zhong T; Lazarescu A; Gan BS; Harth M
    J Rheumatol; 2004 Oct; 31(10):2076-8. PubMed ID: 15468379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leflunomide, a new disease-modifying drug for treating active rheumatoid arthritis in methotrexate-controlled phase II clinical trial.
    Bao C; Chen S; Gu Y; Lao Z; Ni L; Yu Q; Xu J; Li X; Liu J; Sun L; He P; Ma J; Xu S; Ding C
    Chin Med J (Engl); 2003 Aug; 116(8):1228-34. PubMed ID: 12935395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved functional ability in patients with rheumatoid arthritis--longterm treatment with leflunomide versus sulfasalazine. European Leflunomide Study Group.
    Kalden JR; Scott DL; Smolen JS; Schattenkirchner M; Rozman B; Williams BD; Kvien TK; Jones P; Williams RB; Oed C; Rosenburg R;
    J Rheumatol; 2001 Sep; 28(9):1983-91. PubMed ID: 11550964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of leflunomide 10 mg versus 20 mg once daily in patients with active rheumatoid arthritis: multinational double-blind, randomized trial.
    Poór G; Strand V;
    Rheumatology (Oxford); 2004 Jun; 43(6):744-9. PubMed ID: 15026583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alopecia areata in a patient with rheumatoid arthritis treated with leflunomide.
    Gottenberg JE; Venancie PY; Mariette X
    J Rheumatol; 2002 Aug; 29(8):1806-7. PubMed ID: 12180755
    [No Abstract]   [Full Text] [Related]  

  • 9. Life-threatening hypertriglyceridemia during leflunomide therapy in a patient with rheumatoid arthritis.
    Laborde F; Loeuille D; Chary-Valckenaere I
    Arthritis Rheum; 2004 Oct; 50(10):3398. PubMed ID: 15476234
    [No Abstract]   [Full Text] [Related]  

  • 10. Leflunomide and rheumatoid arthritis: new preparation. Neither the safest nor the most effective slow-acting antirheumatic drug.
    Prescrire Int; 2001 Apr; 10(52):36-9. PubMed ID: 11718154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of leflunomide on the peripheral nerves in rheumatoid arthritis.
    Richards BL; Spies J; McGill N; Richards GW; Vaile J; Bleasel JF; Youssef PP
    Intern Med J; 2007 Feb; 37(2):101-7. PubMed ID: 17229252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term open-label preliminary study of the safety and efficacy of leflunomide in patients with polyarticular-course juvenile rheumatoid arthritis.
    Silverman E; Spiegel L; Hawkins D; Petty R; Goldsmith D; Schanberg L; Duffy C; Howard P; Strand V
    Arthritis Rheum; 2005 Feb; 52(2):554-62. PubMed ID: 15693001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. When a DMARD fails, should patients switch to sulfasalazine or add sulfasalazine to continuing leflunomide?
    Dougados M; Emery P; Lemmel EM; Zerbini CA; Brin S; van Riel P
    Ann Rheum Dis; 2005 Jan; 64(1):44-51. PubMed ID: 15271770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leflunomide in rheumatoid arthritis: recommendations through a process of consensus.
    Maddison P; Kiely P; Kirkham B; Lawson T; Moots R; Proudfoot D; Reece R; Scott D; Sword R; Taggart A; Thwaites C; Williams E
    Rheumatology (Oxford); 2005 Mar; 44(3):280-6. PubMed ID: 15657072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy and safety of leflunomide in patients with active rheumatoid arthritis: a five-year followup study.
    Kalden JR; Schattenkirchner M; Sörensen H; Emery P; Deighton C; Rozman B; Breedveld F
    Arthritis Rheum; 2003 Jun; 48(6):1513-20. PubMed ID: 12794818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leflunomide.
    Cohen SB; Iqbal I
    Int J Clin Pract; 2003 Mar; 57(2):115-20. PubMed ID: 12661795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of leflunomide versus biologic agents on the costs of care for rheumatoid arthritis in a managed care population.
    Ollendorf DA; Peterson AN; Doyle J; Huse DM
    Am J Manag Care; 2002 May; 8(7 Suppl):S203-13. PubMed ID: 12022236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The safety and efficacy of leflunomide in combination with infliximab in rheumatoid arthritis.
    Hansen KE; Cush J; Singhal A; Cooley DA; Cohen S; Patel SR; Genovese M; Sundaramurthy S; Schiff M
    Arthritis Rheum; 2004 Apr; 51(2):228-32. PubMed ID: 15077264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leflunomide-associated infections in rheumatoid arthritis.
    Jenks KA; Stamp LK; O'Donnell JL; Savage RL; Chapman PT
    J Rheumatol; 2007 Nov; 34(11):2201-3. PubMed ID: 17937473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rheumatoid arthritis treatment with weekly leflunomide: an open-label study.
    Jaimes-Hernández J; Robles-San Román M; Suárez-Otero R; Dávalos-Zugasti ME; Arroyo-Borrego S
    J Rheumatol; 2004 Feb; 31(2):235-7. PubMed ID: 14760790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.